Arcari Annalisa, Anselmi Elisa, Bernuzzi Patrizia, Bertè Raffaella, Lazzaro Antonio, Moroni Carlo Filippo, Trabacchi Elena, Vallisa Daniele, Vercelli Andrea, Cavanna Luigi
Department of Medical Oncology and Haematology, Hospital of Piacenza, via Taverna 49, 29100 Piacenza, Italy.
Haematologica. 2005 Feb;90(2):ECR09.
Primary pancreatic lymphoma (PPL) is a very rare disease. We report five cases of PPL (4 men and 1 woman, mean age 65 years) diagnosed and treated at our Institution from 1987 to 1997. None of these patients had evidence of extrapancreatic disease and they were categorized as PPL involving pancreas only (stage IE, 3 patients) or pancreas and peripancreatic lymph nodes (stage IIE, 2 patients). The most common presenting symptoms were abdominal pain and weight loss. Imaging techniques showed a mass of the pancreatic head in all cases. The histological diagnosis (3 diffuse-large cell non-Hodgkin's lymphoma and 2 lymphoplasmacytic lymphoma/immunocytoma) was made by ultrasound-guided fine needle aspiration biopsy and tissue core fine-needle biopsy in three patients and by surgery in the remaining two patients. The three patients diagnosed by percutaneous biopsy were treated with chemotherapy as front-line therapy and two of them received also local radiotherapy; one of these patients is still alive in complete remission at 69 months, one died of an unrelated disease at 67 months and one died of lymphoma relapse at 88 months. Two patients underwent pancreaticoduodenectomy plus adjuvant chemotherapy; one of them died of recurrent cholangitis 8 months after surgery while the other one is still alive in complete remission after 160 months. This study shows that: 1) imaging techniques can suggest the suspicion of PPL but are unable to distinguish PPL from pancreatic adenocarcinoma; 2) histological diagnosis can be easily obtained by percutaneous US-guided tissue core biopsy; 3) surgery can be avoided both for diagnosis and therapy but the treatment of choice of PPL may only be evaluated on a larger series of patients.
原发性胰腺淋巴瘤(PPL)是一种非常罕见的疾病。我们报告了1987年至1997年在我院诊断和治疗的5例PPL患者(4例男性,1例女性,平均年龄65岁)。这些患者均无胰腺外疾病的证据,他们被归类为仅累及胰腺的PPL(IE期,3例患者)或胰腺及胰周淋巴结受累的PPL(IIE期,2例患者)。最常见的首发症状是腹痛和体重减轻。影像学检查在所有病例中均显示胰头有肿块。3例患者通过超声引导下细针穿刺活检和组织芯细针活检进行组织学诊断(3例弥漫性大细胞非霍奇金淋巴瘤和2例淋巴浆细胞淋巴瘤/免疫细胞瘤),其余2例患者通过手术进行诊断。3例经皮活检确诊的患者接受化疗作为一线治疗,其中2例还接受了局部放疗;其中1例患者在69个月时仍处于完全缓解状态存活,1例在67个月时死于无关疾病,1例在88个月时死于淋巴瘤复发。2例患者接受了胰十二指肠切除术加辅助化疗;其中1例在术后8个月死于复发性胆管炎,另1例在160个月后仍处于完全缓解状态存活。本研究表明:1)影像学检查可提示PPL的怀疑,但无法将PPL与胰腺腺癌区分开来;2)经皮超声引导下组织芯活检可轻松获得组织学诊断;3)诊断和治疗均可避免手术,但PPL的治疗选择可能仅需在更多患者系列中进行评估。